ELOVL7 and glomerular disorder: Our snRNA-seq approach enabled identification of disease-specific podocyte subpopulations (Fig. 7F), revealing that the ELOVL7 → LC-PUFA → ACSL4 axis constitutes a previously unrecognized pathway driving podocyte vulnerability to lipid peroxidation and glomerular disease progression.